Glycated Haemoglobin Testing Market Trends, Business Overview, Industry Growth and Forecast to 2028

Glycated haemoglobin is used to measure the 3-month mean plasma glucose concentration. A standardized test that indicates the amount of HbA1c, a special form of glycated haemoglobin, in a person’s blood over the past 2 to 4 months. The key factors driving the growth of the glycated haemoglobin testing market are: increasing diabetic patients, increasing geriatric population, technological advances in diabetes diagnosis, growth of home health care market.

 

Key Players

 

• Bio-Rad Laboratories
• Bayer
• Arkray
• Chek Diagnostics
• Diazyme Laboratories
• TaiDoc Technology
• Trinity Biotech
• Siemens Healthcare
• Ceragem Medisys
• Tosoh Bioscience
• Erba Mannheim
• Daiichi Biotech

 

Market – Segmentation

By Type

• Lab Based Test
• Point-of-care Test

 

By Application

• Hospitals
• Diagnostic Centers
• Academic and Research Institutes
• Others

 

Scope of the Report

 

The research study analyses the Global Glycated Haemoglobin Testing Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

 

Recent Developments

 

o Market Overview and growth analysis

o Import and Export Overview

o Volume Analysis

o Current Market Trends and Future Outlook

o Market Opportunistic and Attractive Investment Segment

 

Geographic Coverage 

 

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume

 

Key Questions Answered by Glycated Haemoglobin Testing Market Report :

1. What was the Glycated Haemoglobin Testing Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Glycated Haemoglobin Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Glycated Haemoglobin Testing Market was the market leader in 2021s?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.